AMENDED AND RESTATED CHANGE OF CONTROL AGREEMENTChange of Control Agreement • November 6th, 2008 • Matrixx Initiatives Inc • Pharmaceutical preparations • Arizona
Contract Type FiledNovember 6th, 2008 Company Industry JurisdictionThe Compensation Committee of the Board of Directors believes that it is in the best interests of Matrixx Initiatives, Inc. (“Matrixx”) and its shareholders to take appropriate steps to allay any concerns you may have about your future employment opportunities with Matrixx and its subsidiaries (Matrixx and its subsidiaries are collectively referred to as the “Company”). Accordingly, the Company previously offered to you benefits substantially similar to those contained herein pursuant to that separate Change of Control Agreement, executed between you and the Company in March 2006, as amended in August 2007 (the “Previous Agreement”). Currently, the Company desires to amend and restate the Previous Agreement to incorporate the other previously executed amendment thereto and to amend the definition of Good Reason. As a result, the Compensation Committee has decided to offer to you the benefits described below, which shall amend, restate and supersede the benefits afforded you pursuant to
CHANGE OF CONTROL AGREEMENTChange of Control Agreement • August 9th, 2007 • Matrixx Initiatives Inc • Pharmaceutical preparations • Arizona
Contract Type FiledAugust 9th, 2007 Company Industry JurisdictionThe Compensation Committee of the Board of Directors believes that it is in the best interests of Matrixx Initiatives, Inc. (“Matrixx”), and its shareholders to take appropriate steps to allay any concerns you may have about your future employment opportunities with Matrixx and its subsidiaries (Matrixx and its subsidiaries are collectively referred to as the “Company”). As a result, the Compensation Committee has decided to offer to you the benefits described below. For purposes of Section 11 (Notices), the Company’s current address is 4742 North 24th Street, Suite 455, Phoenix, Arizona 85016.